persistent atrial fibrillation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) patients with persistent atrial fibrillation 2) Hypertensive patients 3) patients planned to be treated with electrical defibrillation 4) patients aged 20 years or older 5) patients who gave their written informed consent to participate
Exclusion criteria
Exclusion criteria: 1) patients with poorly-controlled hypertension (DBP>120 mmHg) 2) patients with complications whose condition is unstable 3) patients with severe renal function impairment or hepatic function impairment 4) patients who are or may be pregnant or lactating 5) patients with a history of allergic reaction to the drug used in the study 6) patients with hyperkalemia 7) patients who are judged to be inappropriate for the entry into the study by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in serum metabolome | — |
Secondary
| Measure | Time frame |
|---|---|
| hs-CRP ANP,BNP Changes in blood-pressure level P Wave Signal-Averaged Electrocardiogram Echocardiographic indices Recurrence of atrial fibrillation | — |
Countries
Japan
Contacts
Kobe University Graduate School of Medicine Division of Cardiovascular Medicine